Ticker
ABCM

Price
15.03
Stock movement up
+0.40 (2.73%)
Company name
Abcam PLC
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
3.44B
Ent value
3.68B
Price/Sales
-
Price/Book
5.25
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-26.75%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ABCM does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF62.63
Price to FCF117.86
Price to EBITDA65.80
EV to EBITDA70.29

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book5.25
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count228.97M
EPS (TTM)-
FCF per share (TTM)0.13

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)0.00
Net income (TTM)0.00
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash95.10M
Net receivables33.20M
Total current assets211.50M
Goodwill364.80M
Intangible assets234.20M
Property, plant and equipment0.00
Total assets986.10M
Accounts payable12.90M
Short/Current long term debt229.70M
Total current liabilities187.20M
Total liabilities330.00M
Shareholder's equity656.10M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)54.95M
Capital expenditures (TTM)25.75M
Free cash flow (TTM)29.20M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital3.72%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open14.76
Daily high15.12
Daily low14.68
Daily Volume69K
All-time high24.30
1y analyst estimate1731.95
Beta0.66
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ABCMS&P500
Current price drop from All-time high-38.15%-13.41%
Highest price drop-47.78%-56.47%
Date of highest drop9 May 20229 Mar 2009
Avg drop from high-19.29%-11.38%
Avg time to new high33 days12 days
Max time to new high383 days1805 days
COMPANY DETAILS
ABCM (Abcam PLC) company logo
Marketcap
3.44B
Marketcap category
Mid-cap
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Employees
1650
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Life sciences research tool supplier Abcam said it will seek to delist from the AIM on London’s stock exchange following a “positive shareholder response”.
September 13, 2022
Abcam plc (NASDAQ: ABCM) (AIM: ABC) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ...
September 12, 2022
Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period en...
July 20, 2022
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
July 13, 2022
Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of In...
June 27, 2022
Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by taking the expected...
June 18, 2022
Abcam (LON:ABC) has had a rough month with its share price down 11%. It is possible that the markets have ignored the...
May 2, 2022
Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record numbe...
March 25, 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Abcam PLC Sponsored ADR (ABCM). While the effectiveness of this highly sought-after metric is question...
March 18, 2022
Next page